Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

AbbVie’s Skyrizi has been approved by the FDA as a treatment for ulcerative colitis, making it the first IL-23 inhibitor indicated for both major types of inflammatory bowel disease (IBD) – UC and ...

ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...

A senior Trump administration official confirmed reports that Gregory Bovino, a top U.S. Border Patrol official,will be leaving Minnesota along with some of the Border Patrol agents deployed to the ...